Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMEPROMAZINE vs LEVOSIMENDAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOMEPROMAZINE vs LEVOSIMENDAN: Safety Overview

Metric LEVOMEPROMAZINE LEVOSIMENDAN
Total FAERS Reports 3,024 183
Deaths Reported 585 37
Death Rate 19.3% 20.2%
Hospitalizations 1,564 103
Average Patient Age 44.1 yrs 49.9 yrs
% Female Patients 47.2% 42.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Marketing Status Discontinued N/A